News Quantified

Stock Stats

News Stats


All News	{{AllNewsCount}}
News Wires	{{NewsWiresCount}}
Media Monitoring	{{MoreOverCount}}
SEC Edgar Filings	{{SecEdgarFilingsCount}}
Upgrades	{{UpgradesCount}}
Downgrades	{{DowngradesCount}}
Initiated	{{InitiatesCount}}
Reiterated	{{ReiteratesCount}}
Last Earnings	{{LastEarnings}}
Last Earnings EPS	{{LastEps}}
Next Earnings	{{NextEarnings}}

Order Stats

Sub-Penny
{{SubPennyStr}}
Odd Lot
{{OddLotStr}}
Avg. bid-ask spread

{{GetAvgBidAskSpreadForScale}}
Avg. bid / ask size
{{GetAvgBidSizeForScale}} {{GetAvgAskSizeForScale}}

Shares at ask / bid
{{SharesAtAsk_AMP_Str}} {{SharesAtBid_AMP_Str}}
Off exchange
{{OffExchange}}

News

Cyclerion's sGC Stimulator Portfolio Generates Revenues to Enable Company Growth [Yahoo! Finance]

Cyclerion’s sGC Stimulator Portfolio Generates Revenues to Enable Company Growth

Form 8-K Cyclerion Therapeutics, For: Dec 13

Form SCHEDULE 13G/A Cyclerion Therapeutics, Filed by: Slate Path Capital LP

Form 4 Cyclerion Therapeutics, For: Nov 21 Filed by: Slate Path Capital LP

Form 10-Q Cyclerion Therapeutics, For: Sep 30

Top News Decliners

6/3 Cyclerion Therapeutics Inc (NASDAQ: CYCN) is now covered by analysts at Credit Suisse Group AG. They set a "neutral" rating on the stock. -18.7%

3/5 Form 8-K Cyclerion Therapeutics, For: Feb 28 -12.0%

5/13 Cyclerion Therapeutics Provides a Corporate and Pipeline Overview as a Newly Launched Public Biopharmaceutical Company -9.4%

6/4 Form 4 Cyclerion Therapeutics, For: Jun 01 Filed by: CONRADES GEORGE H -6.6%

12/31 Form 4 Cyclerion Therapeutics, For: Dec 27 Filed by: Currie Mark G -5.5%

8/12 Cyclerion Therapeutics Reports Second Quarter 2019 Financial Results and Progress on Four Clinical Studies with Data Readouts Anticipated in the Next 12 Months -5.5%

11/27 Cyclerion to Present at the Evercore ISI 2nd Annual HealthCONx Conference -4.8%

9/20 Form 4/A Cyclerion Therapeutics, For: Apr 01 Filed by: Huyett William -3.5%

10/8 Cyclerion Therapeutics and Collaborators to Present New Research on the Sickle Cell Disease Patient Journey at Upcoming Medical Meetings -3.1%

2/7 Form SC 13G Cyclerion Therapeutics, Filed by: FMR LLC -2.9%

Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies

If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.

Click Here To Register For The Live Online Workshop

52 Week High	{{GetCompanyStockInfo.Week52HighValue}} {{GetCompanyStockInfo.Week52HighDate}}
52 Week Low	{{GetCompanyStockInfo.Week52LowValue}} {{GetCompanyStockInfo.Week52LowDate}}

Today’s Volatility	{{VolatilityStr}}
20 Day Volatility	{{Volatility20Str}}

Open	{{GetCompanyStockInfo.Open}}
Prior Close	{{GetCompanyStockInfo.PriorCloseValue}} {{GetCompanyStockInfo.PriorCloseDate}}